Table 2 Evidence of T. gondii IgG seroconversion or reversion and TgERP antibody response in Scottish blood donors (2006–2009)
From: The prevalence and genotypic analysis of Toxoplasma gondii from individuals in Scotland, 2006–2012
Donor | Positive | logODc | Collection period | Date | Status | TgERP ELISA Result (OD) |
|---|---|---|---|---|---|---|
A | N | −0.50 | 1 | May 2006 | 0.20 | |
A | Y | −0.27 | 2 | April 2007 | SEROCONVERTED | 0.29 |
A | Y | −0.28 | 3 | July 2008 | 0.19 | |
B | N | −0.87 | 1 | May 2006 | 0.20 | |
B | N | −0.81 | 2 | August 2006 | 0.21 | |
B | N | −1.01 | 4 | September 2008 | 0.21 | |
B | Y | −0.02 | 4 | January 2009 | SEROCONVERTED | 0.22 |
C | N | −0.89 | 1 | April 2006 | 0.39 | |
C | Y | 0.25 | 3 | May 2008 | SEROCONVERTED | 1.38 # |
C | Y | 0.13 | 4 | September 2008 | 0.38 | |
C | Y | 0.03 | 4 | December 2008 | 0.27 | |
D | N | −0.63 | 1 | May 2006 | 0.22 | |
D | N | −0.77 | 2 | November 2006 | 0.17 | |
D | N | −0.99 | 3 | August 2008 | 0.12 | |
D | Y | 0.00 | 4 | December 2008 | SEROCONVERTED | 0.15 |
E | N | −0.51 | 1 | May 2006 | 0.17 | |
E | Y | 0.12 | 2 | January 2007 | SEROCONVERTED | 0.16 |
F | N | −0.58 | 1 | June 2006 | 0.18 | |
F | N | −0.52 | 2 | September 2006 | 0.22 | |
F | Y | −0.43 | 3 | April 2008 | SEROCONVERTED | 0.20 |
F | N | −0.55 | 3 | July 2008 | REVERSION | 0.23 |
F | Y | −0.22 | 4 | November 2008 | SEROCONVERTED | 0.32 |
G | N | −0.80 | 1 | June 2006 | 0.15 | |
G | N | −0.74 | 2 | October 2006 | 0.24 | |
G | N | −0.74 | 3 | June 2008 | 0.28 | |
G | Y | −0.37 | 4 | November 2008 | SEROCONVERTED | 0.23 |
G | N | −0.93 | 4 | February 2009 | REVERSION | 0.25 |
H | N | −0.66 | 1 | July 2006 | 0.25 | |
H | Y | −0.29 | 4 | February 2009 | SEROCONVERTED | 0.25 |
I | N | −0.79 | 3 | July 2008 | 0.14 | |
I | Y | −0.36 | 4 | December 2008 | SEROCONVERTED | 0.14 |
J | N | −0.79 | 3 | August 2008 | 0.23 | |
J | Y | −0.08 | 4 | December 2008 | SEROCONVERTED | 0.14 |